AI-based Prognostic Imaging Biomarkers for Precision Neurooncology: the ReSPOND Consortium

Authors

Christos Davatzikos
Jill S. Barnholtz-Sloan
Spyridon Bakas
Rivka Colen
Abhishek Mahajan
Carmen Balaña Quintero
Jaume Capellades Font
Josep Puig
Rajan Jain
Andrew E E. Sloan
Chaitra Badve
Daniel S. Marcus
Yoon S. Choi
Seung-Koo Lee
Jong Hee Chang
Laila M. Poisson, Henry Ford HealthFollow
Brent Griffith, Henry Ford HealthFollow
Adam P. Dicker
Adam E. Flanders
Thomas C. Booth
Saima Rathore
Hamed Akbari
Chiharu Sako
Michel Bilello
Gaurav Shukla
Anahita F. Kazerooni
Steven Brem
Robert Lustig
Suyash Mohan
Stephen Bagley
MacLean Nasrallah
Donald M. O'Rourke

Recommended Citation

Davatzikos C, Barnholtz-Sloan JS, Bakas S, Colen R, Mahajan A, Quintero CB, Font JC, Puig J, Jain R, Sloan AE, Badve C, Marcus DS, Choi YS, Lee SK, Chang JH, Poisson LM, Griffith B, Dicker AP, Flanders AE, Booth TC, Rathore S, Akbari H, Sako C, Bilello M, Shukla G, Kazerooni AF, Brem S, Lustig R, Mohan S, Bagley S, Nasrallah M, and O'Rourke DM. AI-based Prognostic Imaging Biomarkers for Precision Neurooncology: the ReSPOND Consortium. Neuro Oncol 2020.

Document Type

Article

Publication Date

3-10-2020

Publication Title

Neuro Oncol

Medical Subject Headings

Artificial Intelligence; Biomarkers; Humans; Medical Oncology; Precision Medicine; Prognosis

PubMed ID

32152622

ePublication

ePub ahead of print

Volume

22

Issue

6

First Page

886

Last Page

888